chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Joint swelling, Pain in extremity, Peripheral swelling, Ultrasound scan, Vaccination site warmth
Clinical narrative: swelling from his elbow to wrist; now his right hand is swollen as well; hot to the touch; Can't use his hand; He has pain in every joint of his hand and fingers.; sore arm; felt like he had flu like symptoms; He was tired and had chills; He was tired and had chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), INFLUENZA LIKE ILLNESS (felt like he had flu like symptoms), JOINT SWELLING (swelling from his elbow to wrist), PERIPHERAL SWELLING (now his right hand is swollen as well) and VACCINATION SITE WARMTH (hot to the touch) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Obesity and Atrial fibrillation. Concurrent medical conditions included Hypertension and Penicillin allergy. Concomitant products included LOSARTAN POTASSIUM (LOSARTAN "AGP") and SPIRONOLACTONE for an unknown indication.   On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm), INFLUENZA LIKE ILLNESS (felt like he had flu like symptoms), CHILLS (He was tired and had chills) and FATIGUE (He was tired and had chills). On 07-Feb-2021, the patient experienced JOINT SWELLING (swelling from his elbow to wrist), PERIPHERAL SWELLING (now his right hand is swollen as well), VACCINATION SITE WARMTH (hot to the touch), FEELING ABNORMAL (Can't use his hand) and ARTHRALGIA (He has pain in every joint of his hand and fingers.). At the time of the report, PAIN IN EXTREMITY (sore arm), INFLUENZA LIKE ILLNESS (felt like he had flu like symptoms), JOINT SWELLING (swelling from his elbow to wrist), PERIPHERAL SWELLING (now his right hand is swollen as well), VACCINATION SITE WARMTH (hot to the touch), FEELING ABNORMAL (Can't use his hand), CHILLS (He was tired and had chills), FATIGUE (He was tired and had chills) and ARTHRALGIA (He has pain in every joint of his hand and fingers.) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Ultrasound scan: negative Negative. On an unknown date, X-ray: negative Negative.         No treatment was reported. Action taken in response to mRNA-1273 was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 24-Apr-2021: TCR
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: X-ray
Clinical narrative: swelling from his elbow to wrist; now his right hand is swollen as well; hot to the touch; Can't use his hand; He has pain in every joint of his hand and fingers.; sore arm; felt like he had flu like symptoms; He was tired and had chills; He was tired and had chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), INFLUENZA LIKE ILLNESS (felt like he had flu like symptoms), JOINT SWELLING (swelling from his elbow to wrist), PERIPHERAL SWELLING (now his right hand is swollen as well) and VACCINATION SITE WARMTH (hot to the touch) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Obesity and Atrial fibrillation. Concurrent medical conditions included Hypertension and Penicillin allergy. Concomitant products included LOSARTAN POTASSIUM (LOSARTAN "AGP") and SPIRONOLACTONE for an unknown indication.   On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm), INFLUENZA LIKE ILLNESS (felt like he had flu like symptoms), CHILLS (He was tired and had chills) and FATIGUE (He was tired and had chills). On 07-Feb-2021, the patient experienced JOINT SWELLING (swelling from his elbow to wrist), PERIPHERAL SWELLING (now his right hand is swollen as well), VACCINATION SITE WARMTH (hot to the touch), FEELING ABNORMAL (Can't use his hand) and ARTHRALGIA (He has pain in every joint of his hand and fingers.). At the time of the report, PAIN IN EXTREMITY (sore arm), INFLUENZA LIKE ILLNESS (felt like he had flu like symptoms), JOINT SWELLING (swelling from his elbow to wrist), PERIPHERAL SWELLING (now his right hand is swollen as well), VACCINATION SITE WARMTH (hot to the touch), FEELING ABNORMAL (Can't use his hand), CHILLS (He was tired and had chills), FATIGUE (He was tired and had chills) and ARTHRALGIA (He has pain in every joint of his hand and fingers.) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Ultrasound scan: negative Negative. On an unknown date, X-ray: negative Negative.         No treatment was reported. Action taken in response to mRNA-1273 was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 24-Apr-2021: TCR
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Bowel movement irregularity, Gait disturbance, Myalgia, Vaccination complication
Clinical narrative: every time i take something to drink i have to use the bathroom immediately; feels sick as a dog; barely can walk; body aches; This spontaneous case was reported by a consumer and describes the occurrence of BOWEL MOVEMENT IRREGULARITY (every time i take something to drink i have to use the bathroom immediately), VACCINATION COMPLICATION (feels sick as a dog), GAIT DISTURBANCE (barely can walk) and MYALGIA (body aches) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     Medical History Information not Reported.     On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, the patient experienced BOWEL MOVEMENT IRREGULARITY (every time i take something to drink i have to use the bathroom immediately), VACCINATION COMPLICATION (feels sick as a dog), GAIT DISTURBANCE (barely can walk) and MYALGIA (body aches). At the time of the report, BOWEL MOVEMENT IRREGULARITY (every time i take something to drink i have to use the bathroom immediately), VACCINATION COMPLICATION (feels sick as a dog), GAIT DISTURBANCE (barely can walk) and MYALGIA (body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication and treatment information were not reported.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site swelling
Clinical narrative: Swelling around injection site; Soreness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness) and VACCINATION SITE SWELLING (Swelling around injection site) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced VACCINATION SITE PAIN (Soreness). On 16-Feb-2021, the patient experienced VACCINATION SITE SWELLING (Swelling around injection site). At the time of the report, VACCINATION SITE PAIN (Soreness) and VACCINATION SITE SWELLING (Swelling around injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.  Treatment information included ice for swelling.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Rash macular
Clinical narrative: redspot; pain and soreness; This spontaneous case was reported by a pharmacist and describes the occurrence of RASH MACULAR (redspot) and PAIN (pain and soreness) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041L20A and 016M20A) for COVID-19 vaccination.     The patient's past medical history included Hypertension since an unknown date. Concurrent medical conditions included Vitamin D low (She does have low Vitamin D as of 09-2020) in September 2020. Concomitant products included LISINOPRIL for Hypertension, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for Vitamin D low.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Jan-2021, the patient experienced RASH MACULAR (redspot) and PAIN (pain and soreness). On 13-Jan-2021, RASH MACULAR (redspot) and PAIN (pain and soreness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash
Clinical narrative: rash/itchiness at the injection site.; rash/itchiness at the injection site.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (rash/itchiness at the injection site.) and VACCINATION SITE RASH (rash/itchiness at the injection site.) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042130A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (rash/itchiness at the injection site.) and VACCINATION SITE RASH (rash/itchiness at the injection site.). At the time of the report, VACCINATION SITE PRURITUS (rash/itchiness at the injection site.) and VACCINATION SITE RASH (rash/itchiness at the injection site.) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Malaise, Pain
Clinical narrative: body soreness and aching; not feeling well; hurting on the joints; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body soreness and aching), MALAISE (not feeling well) and ARTHRALGIA (hurting on the joints) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 011L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (body soreness and aching), MALAISE (not feeling well) and ARTHRALGIA (hurting on the joints). At the time of the report, PAIN (body soreness and aching), MALAISE (not feeling well) and ARTHRALGIA (hurting on the joints) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: redness got bigger; itching at the injection site; redness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (redness got bigger), VACCINATION SITE PRURITUS (itching at the injection site) and VACCINATION SITE ERYTHEMA (redness at the injection site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history was not reported.  Concurrent medical conditions included Osteoarthritis (new diagnosis of possibly rheumatoid or osteoarthritis). Concomitant products included MELOXICAM and CIPROFLOXACIN for an unknown indication.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (itching at the injection site) and VACCINATION SITE ERYTHEMA (redness at the injection site). On 10-Feb-2021, the patient experienced ERYTHEMA (redness got bigger). The patient was treated with DIPHENHYDRAMINE for Itching, at an unspecified dose and frequency. At the time of the report, ERYTHEMA (redness got bigger), VACCINATION SITE PRURITUS (itching at the injection site) and VACCINATION SITE ERYTHEMA (redness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site rash, Vaccination site warmth
Clinical narrative: hot to the touch; extremely sore; red; rash getting bigger/ spreading; A spontaneous report was received from a healthcare professional concerning a 28-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events rash getting bigger  spreading/vaccination site rash,  extremely sore/vaccination site pain, hot to the touch/vaccination site warmth, red/vaccination site erythema.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 8 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 028L20A) intramuscularly for prophylaxis of COVID-19 infection.  On 10 Feb 2021, the patient experienced the event(s) rash getting bigger  spreading.  On an unknown date, the patient experienced events, extremely sore, hot to the touch, red and has spreading on her left arm  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), rash getting bigger  spreading, extremely sore, hot to the touch, red was unknown.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain
Clinical narrative: Body Aches; Headache; Fatigue; A spontaneous report was received from a nurse, concerning herself, a female patient of 53-years-old, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced, headache, body aches and fatigue.  The patient's medical history was not provided. No relevant concomitant medications were reported.  The patient received their first of two planned doses of mRNA-1273 (Batch number: unknown) on 14 Jan 2021, intramuscularly, in the right upper arm. On 09 Feb 2021, prior to the onset of the events, the patient received their second of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly, in the right upper arm for prophylaxis of COVID-19 infection.   On 09- Feb-2021, after the second dose of vaccine, the patient experienced, headache, body aches and fatigue. Treatment of the event included paracetamol.  Action taken with mRNA-1273 in response to the events was not applicable.   The outcome of events, headache, body aches and fatigue, was unknown at the time of this report.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pleurisy
Clinical narrative: A bit sore; I have Pleurisy, pain in my right lung when I move.; A spontaneous report was received from a healthcare professional concerning a 64-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events i have pleurisy, pain in my right lung when i move, a bit sore.  The patient's medical history was not provided. Concomitant medications reported were Medication for asthma, Medication for high blood pressure for drug use for unknown indication.  On 12 Jan 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: Unknown) via unknown route for prophylaxis of COVID-19 infection. On 8 Feb 2021, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot/batch: 132L2OA) via unknown route for prophylaxis of COVID-19 infection.  On 9 Feb 2021, the patient experienced the event(s) i have pleurisy, pain in my right lung when i move. On an unknown date, the patient experienced the event(s) A bit sore.  Treatment details included Tylenol.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), i have pleurisy, pain in my right lung when i move, , a bit sore was unknown.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Nausea, Tachycardia, Throat tightness, Tremor
Clinical narrative: weak; sensation of throat closing; mild tachycardia; shaky; nausea; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of ASTHENIA (weak), THROAT TIGHTNESS (sensation of throat closing), TACHYCARDIA (mild tachycardia), TREMOR (shaky) and NAUSEA (nausea) in a 21-year-old female patient who received mRNA-1273 (batch no. 011M20A) for COVID-19 vaccination.     The patient's past medical history included Obesity and Anxiety. Concurrent medical conditions included Penicillin allergy (Allergies to Penicillin and Sulfa).    On an unknown date, the patient received dose of mRNA-1273 (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (weak), THROAT TIGHTNESS (sensation of throat closing), TACHYCARDIA (mild tachycardia), TREMOR (shaky) and NAUSEA (nausea). The patient was treated with EPINEPHRINE (intramuscular) at a dose of 0.03 mg; FEXOFENADINE HYDROCHLORIDE (ALLEGRA) at an unspecified dose and frequency and FAMOTIDINE at an unspecified dose and frequency. At the time of the report, ASTHENIA (weak), THROAT TIGHTNESS (sensation of throat closing), TACHYCARDIA (mild tachycardia), TREMOR (shaky) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Intramuscular) was unknown.   For mRNA-1273 (Intramuscular), the reporter considered ASTHENIA (weak), THROAT TIGHTNESS (sensation of throat closing), TACHYCARDIA (mild tachycardia), TREMOR (shaky) and NAUSEA (nausea) to be possibly related.    This case was linked to MOD-2021-055838, MOD-2021-029012, MOD-2021-032365, MOD-2021-055838 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 10-Feb-2021: No new information was received.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Injection site pain
Clinical narrative: Did not has enough strength to pull herself up; Pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Did not has enough strength to pull herself up) and INJECTION SITE PAIN (Pain at injection site) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced ASTHENIA (Did not has enough strength to pull herself up) and INJECTION SITE PAIN (Pain at injection site). At the time of the report, ASTHENIA (Did not has enough strength to pull herself up) and INJECTION SITE PAIN (Pain at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headache off and on mostly on; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache off and on mostly on) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache off and on mostly on). At the time of the report, HEADACHE (headache off and on mostly on) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Pain in extremity
Clinical narrative: little bit of a sore arm; redness on the site of the injection; arm was itchy; became more swollen; hardness; This spontaneous case was reported by a nurse and describes the occurrence of PAIN IN EXTREMITY (little bit of a sore arm), INJECTION SITE ERYTHEMA (redness on the site of the injection), INJECTION SITE PRURITUS (arm was itchy), INJECTION SITE SWELLING (became more swollen) and INJECTION SITE INDURATION (hardness) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, the patient experienced INJECTION SITE PRURITUS (arm was itchy), INJECTION SITE SWELLING (became more swollen) and INJECTION SITE INDURATION (hardness). On an unknown date, the patient experienced PAIN IN EXTREMITY (little bit of a sore arm) and INJECTION SITE ERYTHEMA (redness on the site of the injection). At the time of the report, PAIN IN EXTREMITY (little bit of a sore arm) and INJECTION SITE ERYTHEMA (redness on the site of the injection) outcome was unknown and INJECTION SITE PRURITUS (arm was itchy), INJECTION SITE SWELLING (became more swollen) and INJECTION SITE INDURATION (hardness) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pyrexia
Clinical narrative: fever; muscle pain; headache; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of PYREXIA (fever), MYALGIA (muscle pain) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Cancer (Breast cancer and on chemotherapy treatment).    On 04-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever), MYALGIA (muscle pain) and HEADACHE (headache). At the time of the report, PYREXIA (fever), MYALGIA (muscle pain) and HEADACHE (headache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were not reported. No treatment information was provided.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Joint stiffness, Joint swelling, Musculoskeletal stiffness, Pain in extremity
Clinical narrative: Wrist stiffness; Swollen wrist; Hand stiffness; Finger stiffness; Swollen fingers; Finger pain; Finger pain; Swollen fingers; Swollen hand; Hand pain; Wrist pain; This spontaneous case was reported by a consumer and describes the occurrence of JOINT STIFFNESS (Wrist stiffness), JOINT SWELLING (Swollen wrist), MUSCULOSKELETAL STIFFNESS (Hand stiffness), MUSCULOSKELETAL STIFFNESS (Finger stiffness) and the first episode of PERIPHERAL SWELLING (Swollen fingers) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypothyroidism. Concomitant products included ATORVASTATIN and THYROID (ARMOUR THYROID) for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced JOINT STIFFNESS (Wrist stiffness), JOINT SWELLING (Swollen wrist), MUSCULOSKELETAL STIFFNESS (Hand stiffness), MUSCULOSKELETAL STIFFNESS (Finger stiffness), the first episode of PERIPHERAL SWELLING (Swollen fingers), the first episode of PAIN IN EXTREMITY (Finger pain), the second episode of PAIN IN EXTREMITY (Finger pain), the second episode of PERIPHERAL SWELLING (Swollen fingers), PERIPHERAL SWELLING (Swollen hand), PAIN IN EXTREMITY (Hand pain) and ARTHRALGIA (Wrist pain). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, JOINT STIFFNESS (Wrist stiffness), JOINT SWELLING (Swollen wrist), MUSCULOSKELETAL STIFFNESS (Hand stiffness), MUSCULOSKELETAL STIFFNESS (Finger stiffness), the last episode of PAIN IN EXTREMITY (Finger pain), the last episode of PERIPHERAL SWELLING (Swollen fingers), PERIPHERAL SWELLING (Swollen hand), PAIN IN EXTREMITY (Hand pain) and ARTHRALGIA (Wrist pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: Wrist stiffness; Swollen wrist; Hand stiffness; Finger stiffness; Swollen fingers; Finger pain; Finger pain; Swollen fingers; Swollen hand; Hand pain; Wrist pain; This spontaneous case was reported by a consumer and describes the occurrence of JOINT STIFFNESS (Wrist stiffness), JOINT SWELLING (Swollen wrist), MUSCULOSKELETAL STIFFNESS (Hand stiffness), MUSCULOSKELETAL STIFFNESS (Finger stiffness) and the first episode of PERIPHERAL SWELLING (Swollen fingers) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypothyroidism. Concomitant products included ATORVASTATIN and THYROID (ARMOUR THYROID) for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced JOINT STIFFNESS (Wrist stiffness), JOINT SWELLING (Swollen wrist), MUSCULOSKELETAL STIFFNESS (Hand stiffness), MUSCULOSKELETAL STIFFNESS (Finger stiffness), the first episode of PERIPHERAL SWELLING (Swollen fingers), the first episode of PAIN IN EXTREMITY (Finger pain), the second episode of PAIN IN EXTREMITY (Finger pain), the second episode of PERIPHERAL SWELLING (Swollen fingers), PERIPHERAL SWELLING (Swollen hand), PAIN IN EXTREMITY (Hand pain) and ARTHRALGIA (Wrist pain). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, JOINT STIFFNESS (Wrist stiffness), JOINT SWELLING (Swollen wrist), MUSCULOSKELETAL STIFFNESS (Hand stiffness), MUSCULOSKELETAL STIFFNESS (Finger stiffness), the last episode of PAIN IN EXTREMITY (Finger pain), the last episode of PERIPHERAL SWELLING (Swollen fingers), PERIPHERAL SWELLING (Swollen hand), PAIN IN EXTREMITY (Hand pain) and ARTHRALGIA (Wrist pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Bone pain, Fatigue, Headache, Sleep disorder
Clinical narrative: bones hurt; takes all of my energy to get up; had a rough night.; fatigued; severe headache; This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (bones hurt), ASTHENIA (takes all of my energy to get up), SLEEP DISORDER (had a rough night.), FATIGUE (fatigued) and HEADACHE (severe headache) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BONE PAIN (bones hurt), ASTHENIA (takes all of my energy to get up), SLEEP DISORDER (had a rough night.), FATIGUE (fatigued) and HEADACHE (severe headache). The patient was treated with ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, BONE PAIN (bones hurt), ASTHENIA (takes all of my energy to get up), SLEEP DISORDER (had a rough night.), FATIGUE (fatigued) and HEADACHE (severe headache) outcome was unknown.            No concomitant product was reported by the reporter  Treatment medication included Aspirin   Most recent FOLLOW-UP information incorporated above includes: On 24-Apr-2021: TCR / NNI
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash behind left ear; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash behind left ear) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.).    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced RASH (Rash behind left ear). The patient was treated with HYDROCORTISONE ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, RASH (Rash behind left ear) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included hydrocortisone.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 24-Apr-2021: NNI
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pyrexia
Clinical narrative: chills; headache; fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), CHILLS (chills) and HEADACHE (headache) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced PYREXIA (fever) and HEADACHE (headache). On 14-Feb-2021 at 2:00 AM, the patient experienced CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) for Fever, at an unspecified dose and frequency. On 14-Feb-2021 at 4:00 AM, CHILLS (chills) had resolved. On 15-Feb-2021 at 11:00 AM, PYREXIA (fever) and HEADACHE (headache) had resolved.            No Concomitant medications was reported .   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Follow up received on 13-Jul-2021, contains Non-Significant Information.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site reaction
Clinical narrative: COVID arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (COVID arm) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jan-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE REACTION (COVID arm). At the time of the report, VACCINATION SITE REACTION (COVID arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Pain in extremity
Clinical narrative: injection spot is red; injection spot is itching; arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was sore), INJECTION SITE ERYTHEMA (injection spot is red) and INJECTION SITE PRURITUS (injection spot is itching) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm was sore). On 10-Feb-2021, the patient experienced INJECTION SITE ERYTHEMA (injection spot is red) and INJECTION SITE PRURITUS (injection spot is itching). On 03-Feb-2021, PAIN IN EXTREMITY (arm was sore) had resolved. At the time of the report, INJECTION SITE ERYTHEMA (injection spot is red) and INJECTION SITE PRURITUS (injection spot is itching) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Ear pain, Oropharyngeal pain
Clinical narrative: Sore Throat; Earache; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore Throat) and EAR PAIN (Earache) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced OROPHARYNGEAL PAIN (Sore Throat) and EAR PAIN (Earache). At the time of the report, OROPHARYNGEAL PAIN (Sore Throat) and EAR PAIN (Earache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication were not reported  Treatment medication information were not reported   Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: Follow Up received on 26-Apr-2021 contains non significant information
Sex: M
Vaccine: COVID19
Symptoms: Productive cough
Clinical narrative: coughing up green mucus; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCTIVE COUGH (coughing up green mucus) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCTIVE COUGH (coughing up green mucus). At the time of the report, PRODUCTIVE COUGH (coughing up green mucus) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nasal congestion, Peripheral swelling, Rash
Clinical narrative: swelling and rash on her arm (opposite to injection); swelling and rash on her arm (opposite to injection); Headache; stuffy nose; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), NASAL CONGESTION (stuffy nose), PERIPHERAL SWELLING (swelling and rash on her arm (opposite to injection)) and RASH (swelling and rash on her arm (opposite to injection)) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, the patient experienced HEADACHE (Headache) and NASAL CONGESTION (stuffy nose). On 04-Feb-2021, the patient experienced PERIPHERAL SWELLING (swelling and rash on her arm (opposite to injection)) and RASH (swelling and rash on her arm (opposite to injection)). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) for Rash, at an unspecified dose and frequency. On 25-Jan-2021, HEADACHE (Headache) and NASAL CONGESTION (stuffy nose) had resolved. At the time of the report, PERIPHERAL SWELLING (swelling and rash on her arm (opposite to injection)) and RASH (swelling and rash on her arm (opposite to injection)) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Cystitis, Urinary tract infection
Clinical narrative: UTI/ bladder infection; Bladder infection; This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (UTI/ bladder infection) and CYSTITIS (Bladder infection) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     The patient's past medical history included UTI since an unknown date. Concomitant products included NITROFURANTOIN for an unknown indication.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced URINARY TRACT INFECTION (UTI/ bladder infection) and CYSTITIS (Bladder infection). At the time of the report, URINARY TRACT INFECTION (UTI/ bladder infection) and CYSTITIS (Bladder infection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Nausea, Vomiting
Clinical narrative: feel sick; nausea; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (feel sick), NAUSEA (nausea) and VOMITING (vomiting) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced ILLNESS (feel sick), NAUSEA (nausea) and VOMITING (vomiting). At the time of the report, ILLNESS (feel sick), NAUSEA (nausea) and VOMITING (vomiting) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided. Upon internal review on 04-Aug-2021, the age was corrected to 37 years.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Arthralgia, Pain in extremity, Vaccination site pain
Clinical narrative: She has soreness in arm; Stomach ache; Pain in shoulder near collar bone; Pain in arm of injection; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (She has soreness in arm), ABDOMINAL PAIN UPPER (Stomach ache), ARTHRALGIA (Pain in shoulder near collar bone) and VACCINATION SITE PAIN (Pain in arm of injection) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced VACCINATION SITE PAIN (Pain in arm of injection). On 17-Feb-2021, the patient experienced PAIN IN EXTREMITY (She has soreness in arm), ABDOMINAL PAIN UPPER (Stomach ache) and ARTHRALGIA (Pain in shoulder near collar bone). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at a dose of 1 dosage form. On 11-Feb-2021, VACCINATION SITE PAIN (Pain in arm of injection) had resolved. At the time of the report, PAIN IN EXTREMITY (She has soreness in arm), ABDOMINAL PAIN UPPER (Stomach ache) and ARTHRALGIA (Pain in shoulder near collar bone) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant medication not reported.   This case was linked to MOD-2021-175651 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2021: updated outcome of the events to recovered.
Sex: M
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Itching; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no reported medical history).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (Itching). At the time of the report, PRURITUS (Itching) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  Treatment details included Calazime cream.  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash, Pruritus, Rash
Clinical narrative: itching at injection site after a week of first vaccine; rash at the injection site after a week of first vaccine; Skin rash; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of PRURITUS (itching at injection site after a week of first vaccine), INJECTION SITE RASH (rash at the injection site after a week of first vaccine) and RASH (Skin rash) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced PRURITUS (itching at injection site after a week of first vaccine), INJECTION SITE RASH (rash at the injection site after a week of first vaccine) and RASH (Skin rash). At the time of the report, PRURITUS (itching at injection site after a week of first vaccine), INJECTION SITE RASH (rash at the injection site after a week of first vaccine) and RASH (Skin rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   concomitant medication information is not provided.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Faeces discoloured
Clinical narrative: stool turned black; This spontaneous case was reported by a consumer and describes the occurrence of FAECES DISCOLOURED (stool turned black) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     The patient's past medical history included Migraine and Depression. Concomitant products included VITAMIN C [ASCORBIC ACID] and COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, the patient experienced FAECES DISCOLOURED (stool turned black). At the time of the report, FAECES DISCOLOURED (stool turned black) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications included HRD medicine, depression medicine, migraine medicine and hemapoex vitamin. No treatment information was reported.
Sex: U
Vaccine: COVID19
Symptoms: Adverse reaction
Clinical narrative: worse reactions; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (worse reactions) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (worse reactions). At the time of the report, ADVERSE REACTION (worse reactions) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-029147 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-029147:
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Diarrhoea, Exposure to SARS-CoV-2, SARS-CoV-2 test, Vomiting
Clinical narrative: Exposed to Covid-19; Diarrhea; Chested cough; Vomits; This spontaneous case was reported by a nurse and describes the occurrence of EXPOSURE TO SARS-COV-2 (Exposed to Covid-19), DIARRHOEA (Diarrhea), COUGH (Chested cough) and VOMITING (Vomits) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy, Drug allergy, Celiac disease and Asthma. Concomitant products included VITAMINS NOS for an unknown indication.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced DIARRHOEA (Diarrhea), COUGH (Chested cough) and VOMITING (Vomits). On an unknown date, the patient experienced EXPOSURE TO SARS-COV-2 (Exposed to Covid-19). At the time of the report, EXPOSURE TO SARS-COV-2 (Exposed to Covid-19), DIARRHOEA (Diarrhea), COUGH (Chested cough) and VOMITING (Vomits) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, SARS-CoV-2 test: negative (Negative) Negative, negative (Negative) Negative and negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details were not reported by the reporter.